[1]

吴在德.外科学[M].5版.北京:人民卫生出版社, 2001:342.

吴在德.外科学[M].5版.北京:人民卫生出版社, 2001:342.

[2] Gruber JJ, Colevas AD.Differentiated thyroid cancer:focus on emerging treatments for radioactive iodine-refractory patients[J].Oncologist, 2015, 20(2):113-126.DOI:10.1634/theoncologist.2014-0313.
[3] Zhang WD, Liu DR, Feng CC, et al.Management of differentiated thyroid carcinoma with bone metastasis:a case report and review of the Chinese literature[J].J Zhejiang Univ Sci B, 2014, 15(12):1081-1087.DOI:10.1631/jzus.B1400124.
[4] 许艳红, 宋红俊, 邱忠领, 等.以骨转移为首发症状的分化型甲状腺癌的临床特征与生存分析[J].肿瘤, 2011, 31(6):538-541.DOI:10.3781/j.issn.1000-7431.2011.06.012.
Xu YH, Song HJ, Qiu ZL, et al.Differentiated thyroid carcinoma patients with bone metastasis as the initial presentation:clinical characteristics and survival analysis[J].Tumor, 2011, 31(6):538-541.  doi: 10.3781/j.issn.1000-7431.2011.06.012
[5] Chen Y, Stanton RE, Holst RJ, et al.Treatment planning for prostate implant with loose seeds[J].Med Phys, 1997, 24(7):1141-1145.  doi: 10.1118/1.598016
[6] 陈志军, 涂新华, 周爱清, 等.125I粒子组织间植入治疗2例恶性肿瘤放化疗失败病例临床分析[J].国际放射医学核医学杂志, 2006, 30(3):180-182.DOI:10.3760/cma.j.issn.1673-4114.2006.03.016.
Chen ZJ, Tu XH, Zhou AQ, et al.Clinical analysis of 125I seed implants in worst-casts of the malignant tumors after radiography and chemotherapy[J].Int J Radiat Med Nucl Med, 2006, 30(3):180-182.  doi: 10.3760/cma.j.issn.1673-4114.2006.03.016